Big Pharma seeks patients in India's remote corners
Companies taking a longer-term stance to understand the markets, hoping to capture market share in future
Mumbai
FIRST, foreign food brands flooded India with chips, cookies and soft drinks that fundamentally changed the nation's eating habits. Now, Big Pharma wants to cash in on an upsurge in cases of diabetes and heart disease in the country's most distant corners.
Global pharmaceutical companies, from Indianapolis-based Eli Lilly & Co to Switzerland's Novartis AG, are heading into smaller cities and rural areas to learn about the healthcare needs of about 70 per cent of the population. These remote regions of the developing world are the final frontier for the international drug industry.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Restaurant Brands tops estimates as Burger King overhaul pays off
Walmart to shut all health centers in US over lack of profitability
Coca-Cola raises annual sales forecast on global demand, higher prices
Dying salmon trouble Norway’s vast fish-farm industry
Fast-fashion giant Shein wants to sell skincare, toothpaste and toys, too
Billionaire Geiger is said to near US$7 billion L’Occitane buyout